A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: The increase of CTX-M-15 in the ICU

Epidemiology and Infection

Volumn 138, Issue 2, 2010, Pages 253-263

  Shu, J C ^a   Chia, J H ^a,b   Kuo, A J ^a,b   Su, L H ^a,b   Wu, T L ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

CTX M 15; ESBL; ICUs

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 3; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; NONHUMAN; PLASMID; PREVALENCE; TAIWAN; UNIVERSITY HOSPITAL; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; INFECTION CONTROL; KLEBSIELLA INFECTION; METABOLISM; MICROBIOLOGY; RETROSPECTIVE STUDY; TIME;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN; TIME FACTORS;

EID: 74949118679     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990409     Document Type: Article

References (44)

1. Bauernfeind A, Horl G. Novel R-factor borne b-lactamase of Escherichia coli conferring resistance to cephalosporins. Infection 1987; 15: 257-259.
2. Hirakata Y, et al. Regional variation in the prevalence of extended-spectrum b-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998- 2002). Diagnostic Microbiology and Infectious Disease 2005; 52: 323-329.
3. Knothe H, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-317.
4. Bush K. New b-lactamases in gram-negative bacteria : diversity and impact on the selection of antimicrobial therapy. Clinical Infectious Diseases 2001; 32: 1085-1089.
5. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum b-lactamases. Clinical Infectious Diseases 2006; 42 (Suppl. 4) : S153-S163.
6. Wu TL, et al. Dissemination of extended-spectrum b-lactamase-producing Enterobacteriaceae in intensive care units of a medical center in Taiwan. Microbial Drug Resistance 2006; 12: 203-209.
7. Yu WL, Chuang YC, Walther-Rasmussen J. Extendedspectrum b-lactamases in Taiwan: epidemiology, detection, treatment and infection control. Journal of Microbiology, Immunology, and Infection 2006; 39: 264-277.
8. Garner JS, et al. CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988; 16: 128-140.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA, 2005.
10. Su LH, et al. Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent restriction site PCR. Journal of Hospital Infection 2000; 46: 110-117.
11. Chia JH, et al. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M b-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. Journal of Clinical Microbiology 2005; 43: 4486-4491.
12. Mabilat C, Goussard S. PCR detection and identification of genes for extended-spectrum b-lactamases. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic Molecular Microbiology: Principle and Applications. Washington DC: American Society for Microbiology, 1993, pp. 553-559.
13. Rasheed JK, et al. Evolution of extended-spectrum blactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrobial Agents and Chemotherapy 1997; 41: 647-653.
14. Ma L, et al. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum b-lactamase isolated from Escherichia coli. Antimicrobial Agents and Chemotherapy 2002; 46: 1985-1988.
15. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-b-lactamases produced by Escherichia coli and Klebsiella spp. Journal of Clinical Microbiology 2004; 42: 5715-5721.
16. Jean SS, et al. Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan. European Journal of Clinical Microbiology and Infectious Diseases 2009; 28: 215-220.
17. Rossi F, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Journal of Antimicrobial Chemotherapy 2006; 58: 205-210.
18. Paterson DL, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). Journal of Antimicrobial Chemotherapy 2005; 55: 965-973.
19. Ko KS, et al. Prevalence and characterization of extended- spectrum b-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagnostic Microbiology and Infectious Disease 2008; 61: 453-459.
20. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. International Journal of Antimicrobial Agents 2005; 26: 463-472.
21. Livermore DM. Defining an extended-spectrum blactamase. Clinical Microbiology and Infection 2008; 14 (Suppl. 1) : 3-10.
22. Livermore DM, et al. CTX-M: changing the face of ESBLs in Europe. Journal of Antimicrobial Chemotherapy 2007; 59: 165-174.
23. Bush K. Extended-spectrum b-lactamases in North America, 1987-2006. Clinical Microbiology and Infection 2008; 14 (Suppl. 1) : 134-143.
24. Kiratisin P, et al. Molecular characterization and epidemiology of extended-spectrum b-lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrobial Agents and Chemotherapy 2008; 52: 2818-2824.
25. Karim A, et al. Plasmid-mediated extended-spectrum b-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiology Letters 2001; 201: 237-241.
26. Woodford N, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum b-lactamases in the UK. Journal of Antimicrobial Chemotherapy 2004; 54: 735-743.
27. Gonullu N, et al. Dissemination of CTX-M-15 b-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey. Journal of Clinical Microbiology 2008; 46: 1110-1112.
28. Ma L, et al. Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum b-lactamases. Antimicrobial Agents and Chemotherapy 2009; 53: 104-111.
29. Navon-Venezia S, et al. Dissemination of the CTX-M- 25 family b-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. Journal of Antimicrobial Chemotherapy 2008; 62: 289-295.
30. Zong Z, et al. Dominance of blaCTX-M within an Australian extended-spectrum b-lactamase gene pool. Antimicrobial Agents and Chemotherapy 2008; 52: 4198-4202.
31. Liu SY, et al. Characterisation of plasmids encoding CTX-M-3 extended-spectrum b-lactamase from Enterobacteriaceae isolated at a university hospital in Taiwan. International Journal of Antimicrobial Agents 2007; 29: 440-445.
32. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 2008; 13(47).
33. Lewis 2nd JS, et al. First report of the emergence of CTX-M-type extended-spectrum b-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrobial Agents and Chemotherapy 2007; 51: 4015-4021.
34. Zhanel GG, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial Agents and Chemotherapy 2008; 52: 1430-1437.
35. Hawkey PM. Prevalence and clonality of extendedspectrum b-lactamases in Asia. Clinical Microbiology and Infection 2008; 14 (Suppl. 1) : 159-165.
36. Yu WL, et al. Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 blactamase in Taiwan. Antimicrobial Agents and Chemotherapy 2004; 48: 362-363.
37. Pitout JD, et al. Molecular epidemiology of CTXM- producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrobial Agents and Chemotherapy 2007; 51: 1281-1286.
38. Lau SH, et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 b-lactamase, all belong to the international O25:H4-ST131 clone. Journal of Antimicrobial Chemotherapy 2008; 62: 1241-1244.
39. Nicolas-Chanoine MH, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2008; 61: 273-281.
40. Suzuki S, et al. Change in the prevalence of extendedspectrum b-lactamase producing Escherichia coli in Japan by clonal spread. Journal of Antimicrobial Chemotherapy 2009; 63: 72-79.
41. Mazzariol A, et al. Detection of a new SHV-type extended-spectrum b-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in the Netherlands. Antimicrobial Agents and Chemotherapy 2007; 51: 1082-1084.
42. Romero ED, et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum b-lactamases. Diagnostic Microbiology and Infectious Disease 2007; 59: 433-437.
43. Liu JH, et al. Detection and characterisation of CTX-M and CMY-2 b-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. International Journal of Antimicrobial Agents 2007; 29: 576-581.
44. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I. First description of CTX-M b-lactamase-producing clinical Escherichia coli isolates from Egypt. International Journal of Antimicrobial Agents 2006; 27: 545-548.